Stockscreener 앱 받기
7.99
0.50%
0.04
시간 외 거래:
7.99
Decoy Therapeutics Inc 주식(DCOY)의 최신 뉴스
Decoy Therapeutics partners with Quantori on AI peptide platform By Investing.com - Investing.com Nigeria
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - Lelezard
Decoy Therapeutics Inc. Earnings and Revenue – GETTEX:FP11 - TradingView
Debt to equity ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBIT per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Price to cash flow ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Free cash flow per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Net margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Revenue per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Operating margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Net current asset value per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Enterprise value to EBITDA ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Non-controlling/minority interest of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Price to book ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Total operating expenses of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
CapEx per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Equity in earnings of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBIT of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Total debt per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Debt to assets ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Total common shares outstanding of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Operating income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Enterprise value of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBITDA margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Discontinued operations of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Decoy Therapeutics Inc. Statistics – GETTEX:FP11 - TradingView
Gross profit of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Taxes of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Preferred dividends of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Diluted shares outstanding of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
After tax other income/expense of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Diluted net income available to common stockholders of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Pretax income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Net income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Non-operating income (total) of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
EBITDA of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Free float of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Decoy Therapeutics Inc. Revenue Breakdown – GETTEX:FP11 - TradingView
Number of employees of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView
Decoy Therapeutics (DCOY) Partners with Quantori to Enhance Anti - GuruFocus
Decoy Therapeutics partners with Quantori on AI peptide platform - Investing.com
Decoy Therapeutics enters collaboration with Quantori - TipRanks
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform – NEWSnet Michigan - michigan.newsnetmedia.com
Google Cloud-funded AI aims up to 100-fold faster antiviral peptide design - Stock Titan
Decoy Therapeutics Inc. Revenue Breakdown – MUN:FP11 - TradingView
Decoy Therapeutics Inc. Earnings and Revenue – MUN:FP11 - TradingView
Free cash flow of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total equity of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total assets of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total liabilities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Cash from financing activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Cash from operating activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total debt of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Cash from investing activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Decoy Therapeutics (FRA:FP11) Shiller PE Ratio : (As of Mar. 11, 2026) - GuruFocus
Debt to assets ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Net margin % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
CapEx per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
EBITDA per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Long term debt to total equity ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Current ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Return on invested capital % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Gross margin % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Book value per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Total common shares outstanding of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Price to book ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Price to cash flow ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Debt to equity ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Enterprise value to EBITDA ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
EBIT per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Operating margin % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Quick ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Cash per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
Net current asset value per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView
1.20%
0.06%
자본화:
|
볼륨(24시간):